Kinnate Biopharma Inc (DELISTED) (KNTE:DL)
2.65
0.00 (0.00%)
USD |
NASDAQ |
Apr 03, 16:00
Kinnate Biopharma Enterprise Value: -28.89M for April 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 03, 2024 | -28.89M |
| April 02, 2024 | -28.89M |
| April 01, 2024 | -28.41M |
| March 28, 2024 | -28.41M |
| March 27, 2024 | -28.41M |
| March 26, 2024 | -29.83M |
| March 25, 2024 | -28.89M |
| March 22, 2024 | -28.89M |
| March 21, 2024 | -28.89M |
| March 20, 2024 | -28.89M |
| March 19, 2024 | -33.61M |
| March 18, 2024 | -33.61M |
| March 15, 2024 | -33.14M |
| March 14, 2024 | -34.55M |
| March 13, 2024 | -34.08M |
| March 12, 2024 | -33.76M |
| March 11, 2024 | -34.23M |
| March 08, 2024 | -32.34M |
| March 07, 2024 | -33.05M |
| March 06, 2024 | -32.82M |
| March 05, 2024 | -32.34M |
| March 04, 2024 | -31.87M |
| March 01, 2024 | -31.87M |
| February 29, 2024 | -37.53M |
| February 28, 2024 | -36.59M |
| Date | Value |
|---|---|
| February 27, 2024 | -36.12M |
| February 26, 2024 | -38.71M |
| February 23, 2024 | -35.65M |
| February 22, 2024 | -38.00M |
| February 21, 2024 | -39.42M |
| February 20, 2024 | -34.23M |
| February 16, 2024 | -33.76M |
| February 15, 2024 | -46.97M |
| February 14, 2024 | -47.44M |
| February 13, 2024 | -48.38M |
| February 12, 2024 | -47.06M |
| February 09, 2024 | -46.12M |
| February 08, 2024 | -45.18M |
| February 07, 2024 | -42.82M |
| February 06, 2024 | -44.71M |
| February 05, 2024 | -46.12M |
| February 02, 2024 | -40.46M |
| February 01, 2024 | -44.00M |
| January 31, 2024 | -42.35M |
| January 30, 2024 | -43.29M |
| January 29, 2024 | -39.99M |
| January 26, 2024 | -42.82M |
| January 25, 2024 | -40.94M |
| January 24, 2024 | -38.58M |
| January 23, 2024 | -38.58M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-119.71M
Minimum
Sep 26 2023
1.804B
Maximum
Dec 09 2020
368.80M
Average
207.60M
Median
Apr 14 2022
Enterprise Value Benchmarks
| XOMA Corp | 282.73M |
| Societal CDMO Inc (DELISTED) | 145.26M |
| NGM Biopharmaceuticals Inc (DELISTED) | -15.65M |
| Avrobio Inc | -28.08M |
| Landos Biopharma Inc | 40.70M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.06M |
| Total Expenses (Quarterly) | 19.10M |
| EPS Diluted (Quarterly) | -0.36 |
| Earnings Yield | -91.32% |